Thalidomide-NH-PEG1-NH2 hydrochloride
≥95%
- Product Code: 106467
CAS:
2154342-56-8
Molecular Weight: | 396.83 g./mol | Molecular Formula: | C₁₇H₂₁ClN₄O₅ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | -20°C, dry, sealed |
Product Description:
Thalidomide-NH-PEG1-NH2 hydrochloride is primarily used in the development of targeted therapies, particularly in the field of cancer treatment. Its structure allows it to act as a linker in antibody-drug conjugates (ADCs), enabling the precise delivery of cytotoxic agents to cancer cells while minimizing damage to healthy tissues. This compound is also explored in proteolysis-targeting chimeras (PROTACs), where it facilitates the degradation of specific proteins involved in disease progression. Additionally, its PEG moiety enhances solubility and stability, making it a valuable component in drug formulation and delivery systems. Research continues to explore its potential in treating inflammatory and autoimmune diseases due to its immunomodulatory properties.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.005 | 10-20 days | ฿3,420.00 |
+
-
|
0.025 | 10-20 days | ฿13,500.00 |
+
-
|
0.100 | 10-20 days | ฿38,250.00 |
+
-
|
Thalidomide-NH-PEG1-NH2 hydrochloride
Thalidomide-NH-PEG1-NH2 hydrochloride is primarily used in the development of targeted therapies, particularly in the field of cancer treatment. Its structure allows it to act as a linker in antibody-drug conjugates (ADCs), enabling the precise delivery of cytotoxic agents to cancer cells while minimizing damage to healthy tissues. This compound is also explored in proteolysis-targeting chimeras (PROTACs), where it facilitates the degradation of specific proteins involved in disease progression. Additionally, its PEG moiety enhances solubility and stability, making it a valuable component in drug formulation and delivery systems. Research continues to explore its potential in treating inflammatory and autoimmune diseases due to its immunomodulatory properties.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :